Last reviewed · How we verify
calcium alginate
calcium alginate is a calcium alginate drug. It is currently in unknown development.
Calcium alginate works by forming a protective barrier around wounds or ulcers to promote healing.
Calcium alginate is a water-insoluble, gelatinous substance used in various applications, including entrapment of enzymes and forming artificial seeds in plant tissue culture. It has been studied in clinical trials for conditions such as triacylglycerol digestion, wounds and injuries, pressure ulcers, orthodontic patients, and actinic keratosis.
At a glance
| Generic name | calcium alginate |
|---|---|
| Drug class | calcium alginate |
| Therapeutic area | Infectious Disease |
| Phase | unknown |
Mechanism of action
Imagine a protective shield that helps to keep a wound clean and moist, allowing it to heal faster. Calcium alginate does this by forming a gel-like barrier that covers the wound, protecting it from bacteria and other irritants. This helps to create an ideal environment for the body to repair damaged tissue.
Approved indications
Common side effects
Key clinical trials
- Effects of 2-Aticyto Complex and D-Ribose on Pain and Clinical Course in Patients With Fibromyalgia (NA)
- The Effectiveness of Silver Alginate (Algidex) Patch in the Prevention of Central Line Infections in Very Low Birth Weight Infants (NA)
- Alginate vs Sucralfate for GERD Symptomatic Relief (PHASE2,PHASE3)
- Clinical Registry Collecting Real World Evidence on Wound Care Treatments
- Assessment of Wound Closure Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers (DFU) and With Living Cellular Skin Substitute in Treating Venous Leg Ulcers (VLU) (NA)
- Accuracy of Digital Mandibular Repositioning in Occlusal Reconstruction for Patients With Disc Displacement (NA)
- Efficacy of a Polyhexanide Biguanide-Based Gel in the Prevention of Biofilm Formation in Pressure Ulcers (EARLY_PHASE1)
- Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- calcium alginate CI brief — competitive landscape report
- calcium alginate updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about calcium alginate
What is calcium alginate?
How does calcium alginate work?
What drug class is calcium alginate in?
What development phase is calcium alginate in?
Related
- Drug class: All calcium alginate drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Infectious Disease
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing